Clinical Research & Reference Standard Compendium
Sermorelin Spray - Scientific Literature
I. Abstract & Overview
Sermorelin is a synthetic 29-residue peptide corresponding to the N-terminal fragment of human growth hormone-releasing hormone, terminating in a C-terminal amide. Its significance is that this truncation retains essentially the full receptor activity of the 44-residue parent hormone, establishing residues one through twenty-nine as the minimal active sequence and making Sermorelin the long-standing reference agonist at the GHRH receptor. Prakash and Goa reviewed the compound in 1999. Because it lacks any N-terminal protecting group, it is cleaved rapidly by the aminopeptidase that acts at the second residue, a liability that later analogs such as Tesamorelin were specifically engineered to overcome. Stepień and colleagues subsequently reported activity in a neuroendocrine tumor cell line, extending interest beyond pituitary models. Research Use Only (RUO).
II. Chemical Specifications
| Molecular Formula | C149H246N44O42S |
|---|---|
| Molar Mass | 3357.9 g/mol (PubChem CID 16132413) |
| CAS Registry Number | 86168-78-7 |
| Amino Acid Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 (29 residues, C-terminal amide; single methionine) |
III. Mechanism & Cellular Signaling Pathways
Sermorelin binds the GHRH receptor, a class B G protein-coupled receptor on pituitary somatotroph cells, using the same recognition surface as the full-length hormone. Receptor activation couples to adenylyl cyclase and raises intracellular cAMP, which activates protein kinase A and leads to phosphorylation of the CREB transcription factor. Phosphorylated CREB drives Pit-1 expression, and Pit-1 sustains transcription of the growth hormone gene, so the compound increases hormone synthesis as well as release. Research shows the mechanism is identical in kind to Tesamorelin because both engage the same receptor, and the meaningful difference lies in durability rather than pharmacology: Sermorelin has no N-terminal protection and is cleaved rapidly, whereas Tesamorelin resists that cleavage. Ghrelin-receptor secretagogues such as Ipamorelin act through a different receptor entirely.
IV. Primary Research Directions
- **Reference GHRH Agonist:** Research shows full receptor activity from the 29-residue fragment, making it the standard against which longer or modified GHRH analogs are benchmarked in cAMP assays.
- **Growth Hormone Release Assays:** Studies indicate increased growth hormone secretion into culture medium, quantified by immunoassay in primary rat pituitary cell preparations.
- **Enzymatic Stability Comparison:** Laboratory investigations pair Sermorelin with Tesamorelin to isolate the contribution of N-terminal protection, since the two share a receptor but differ sharply in degradation rate.
- **Extrapituitary Receptor Signaling:** Stepień and colleagues (2009) report proliferation and secretory changes in the NCI-H727 neuroendocrine cell line, extending GHRH receptor work beyond the pituitary.
- **Minimal Active Sequence Studies:** Research shows residues one through twenty-nine carry the receptor activity of the full hormone, supporting structure-activity work on further truncation and substitution.
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Prakash, A., & Goa, K. L. (1999). 'Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.' BioDrugs, 12(2), 139-157. DOI: 10.2165/00063030-199912020-00007 | PMID: 18031173
- Stepień, T., Sacewicz, M., Lawnicka, H., et al. (2009). 'Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.' Neuropeptides, 43(5), 397-400. DOI: 10.1016/j.npep.2009.08.005 | PMID: 19747727
- Halmos, G., Szabo, Z., Juhasz, E., et al. (2023). 'Signaling mechanism of growth hormone-releasing hormone receptor.' Vitamins and Hormones, 123, 1-26. DOI: 10.1016/bs.vh.2023.06.004 | PMID: 37717982
Sermorelin Spray
Abstract & Overview
Sermorelin is a synthetic 29-residue peptide corresponding to the N-terminal fragment of human growth hormone-releasing hormone, terminating in a C-terminal amide. Its significance is that this truncation retains essentially the full receptor activity of the 44-residue parent hormone, establishing residues one through twenty-nine as the minimal active sequence and making Sermorelin the long-standing reference agonist at the GHRH receptor. Prakash and Goa reviewed the compound in 1999. Because it lacks any N-terminal protecting group, it is cleaved rapidly by the aminopeptidase that acts at the second residue, a liability that later analogs such as Tesamorelin were specifically engineered to overcome. Stepień and colleagues subsequently reported activity in a neuroendocrine tumor cell line, extending interest beyond pituitary models. Research Use Only (RUO).
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (Sermorelin Spray) | 7.80 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 7.80 minutes represents the active compound (Sermorelin Spray). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
Sermorelin binds the GHRH receptor, a class B G protein-coupled receptor on pituitary somatotroph cells, using the same recognition surface as the full-length hormone. Receptor activation couples to adenylyl cyclase and raises intracellular cAMP, which activates protein kinase A and leads to phosphorylation of the CREB transcription factor. Phosphorylated CREB drives Pit-1 expression, and Pit-1 sustains transcription of the growth hormone gene, so the compound increases hormone synthesis as well as release. Research shows the mechanism is identical in kind to Tesamorelin because both engage the same receptor, and the meaningful difference lies in durability rather than pharmacology: Sermorelin has no N-terminal protection and is cleaved rapidly, whereas Tesamorelin resists that cleavage. Ghrelin-receptor secretagogues such as Ipamorelin act through a different receptor entirely.
Primary Research Directions
**Reference GHRH Agonist:** Research shows full receptor activity from the 29-residue fragment, making it the standard against which longer or modified GHRH analogs are benchmarked in cAMP assays.
**Growth Hormone Release Assays:** Studies indicate increased growth hormone secretion into culture medium, quantified by immunoassay in primary rat pituitary cell preparations.
**Enzymatic Stability Comparison:** Laboratory investigations pair Sermorelin with Tesamorelin to isolate the contribution of N-terminal protection, since the two share a receptor but differ sharply in degradation rate.
**Extrapituitary Receptor Signaling:** Stepień and colleagues (2009) report proliferation and secretory changes in the NCI-H727 neuroendocrine cell line, extending GHRH receptor work beyond the pituitary.
**Minimal Active Sequence Studies:** Research shows residues one through twenty-nine carry the receptor activity of the full hormone, supporting structure-activity work on further truncation and substitution.
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Prakash, A., & Goa, K. L. (1999). 'Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.' BioDrugs, 12(2), 139-157. DOI: 10.2165/00063030-199912020-00007 | PMID: 18031173
Stepień, T., Sacewicz, M., Lawnicka, H., et al. (2009). 'Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.' Neuropeptides, 43(5), 397-400. DOI: 10.1016/j.npep.2009.08.005 | PMID: 19747727
Halmos, G., Szabo, Z., Juhasz, E., et al. (2023). 'Signaling mechanism of growth hormone-releasing hormone receptor.' Vitamins and Hormones, 123, 1-26. DOI: 10.1016/bs.vh.2023.06.004 | PMID: 37717982
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
